Osteoporoz Tedavisine Yönelik Kemik Hedefli Plga-Pcl Nanokürelerin Hazırlanması Ve Karakterizasyonu

2012-12-31
There are many therapeutic agents used for treatment of osteoporosis in clinics. However, most of them are not specific to bone and their use mostly gives rise to many side effects. Moreoever, there is a need for frequent systemic administration of these agents. As a solution to these issues, bone targeted drug delivery is being investigated recently. The main principle behind this strategy is that it provides controlled release of the therapeutic agent at the target site. Therefore, many side effects due to use of high dose and the administration frequency of the agent can be lowered. In this Ph.D. study, it is aimed to synthesize raloxifene loaded polymer based-nanospheres conjugated with alendronate and characterize them with in situ and in vitro studies. The hypothesis of the study is that the raloxifene loaded nanospheres conjugated with alendronate will provide targeted delivery of raloxifene to osteoporotic bone and osteogenic effect on mesenchymal stem cells in the bone that will improve effectiveness of raloxifene treatment. Until now, raloxifene loaded microspheres were prepared and characterized by scanning electron microscopy (SEM). SEM examinations showed that all the microspheres had a spherical shape and homogeneous in size distribution. Bone marrow mesenchymal stem cells were isolated from rats in order to investigate the effects of free raloxifene and raloxifene loaded microspheres on viability of the mesenchymal stem cells. In vitro cytotoxicity studies showed that raloxifene did not cause a significant loss in the viability of mesenchymal stem cells. However, incubation of mesenchymal stem cells with raloxifene loaded microspheres lowered the viability of cells. Experiments for release studies and encapsulation efficiency of the microspheres are under study. For release studies, HPLC method has been optimized and the calibration curve of raloxifene has been obtained.

Suggestions

Development of novel controlled release formulations of anti-tnf for rheumatoid arthritis and modeling of release behaviors
Erdemli, Özge; Tezcaner, Ayşen; Keskin, Dilek; Department of Engineering Sciences (2013)
Anti-TNFα drugs are widely used in treatment of rheumatoid arthritis. However, long term use of these drugs involves systemic effects. New era in medication involves controlled delivery systems that will provide local sustained release of drug. This study aims to develop a novel intra-articularly injectable etanercept (ETN) loaded poly(ε-caprolactone) (PCL) or methoxypoly(ethyleneglycol)-poly(ε-caprolactone)-methoxypoly(ethyleneglycol) (MPEG-PCL-MPEG) microspheres (patent pending) for the treatment of chron...
Cloning and initial protein characterization of an estrogen responsive gene: YPEL2
Güpür, Gizem; Muyan, Mesut; Department of Biology (2014)
17β-estradiol (E2), the main circulating estrogen in the body, is involved in physiological regulation of many tissue and organ functions, including mammary tissue. E2 is also involved in target tissue malignancies. E2 regulates cellular proliferation, differentiation and death in target tissues. The lasting effects of E2 on cells are mediated by estrogen receptor and β that are the products of distinct genes and act as transcription factors. Upon binding to E2, the activated ER regulates the expression of ...
Biyouyumlu kemik çimentosu formülasyonlarının geliştirilmesi
Şerbetçi, Kemal; Hasırcı, Nesrin; Akçınar, Orçun; Hasırcı, Vasıf Nejat(2008)
Kemik çimentoları ortopedik cerrahide ve diş hekimliğinde kullanılmakta olup günümüzde ticari olarak en yaygın kullanılanlar polimetilmetakrilat (PMMA) temellidir. Ortopedik cerrahide kemik çimentosu, kemikteki hasarlı bölgelerin onarımında dolgu maddesi olarak; metal protez kullanımında kemik ile metal arasında mekanik bağlantıyı oluşturarak protezin stabilize edilmesini ve bu sayede kemik üzerindeki vücut yükünün homojen dağıtılmasını sağlamak amacıyla kullanılır. Akrilik kemik çimentola...
Characterization of intravenous immunoglobulin-mediated functional changes in innate immune cells
Geçkin, Büşranur; Gürsel, Mayda; Department of Biology (2019)
Intravenous Immunoglobulin (IVIg) is mainly composed of IgG derived from pooled plasma of healthy individuals and used to treat variety of immune diseases. Low dose administration can activate the immune system in case of immunodeficiencies, while high doses suppress immune responses in autoimmune/autoinflammatory conditions. The mechanisms underlying this disparate effect is poorly understood. Herein, we examined the effects of IVIg treatment on the functionality of specific innate immune cell populations ...
Development of gemcitabine and clofazimine coloaded liposomal delivery system for osteosarcom treatment
Çalışkan, Yağmur; Keskin, Dilek; Özen, Can; Department of Biotechnology (2016)
New strategies for more effective treatments need to be developed to cure osteosarcoma patients. Current study was designed to produce a dual drug delivery system with Gemcitabine (GEM) and Clofazimine (CLF) co-loaded liposomes against osteosarcoma diseases. GEM is a second line therapy for osteosarcoma and with combinational use of another regimen it could be much more effective. CLF, an antimycobacterial agent, has been recently recognized as effective on cancer treatment and it was suggested to act on os...
Citation Formats
A. Tezcaner, “Osteoporoz Tedavisine Yönelik Kemik Hedefli Plga-Pcl Nanokürelerin Hazırlanması Ve Karakterizasyonu,” 2012. Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/59343.